S100A8 and neoplasm: Both S100A8/A9 and CA15-3 serum levels were considerably high in patients with breast cancer, and it was positively linked with tumor size, showing that the S100A8/A9 heterodimer might be regarded a possible biomarker for BRCA diagnosis and prognosis [34].